Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

AHU-377 hemicalcium salt - CAS# 1369773-39-6 Catalog No.:M6489-2 Targeting the multiple myeloma hypoxic

SKU: 27420493775

4.1
USD35.00 USD84.00

Pay in 4 interest-free payments of $8.75 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 17 - Aug 22

Live Spec

AHU-377 hemicalcium salt - CAS# 1369773-39-6 Catalog No.:M6489-2 Targeting the multiple myeloma hypoxicAHU 377 hemicalcium salt, CAS No. 1369773 39 6, is angiotensin receptor neprilysin inhibitor being studied for use in combination with valsartan for heart failure. Sacubitril is a prodrug that is activated to LBQ657 by de ethylation via esterases. LBQ657 inhibits the enzyme neprilysin, which is responsible for the degradation of atrial and brain natriuretic peptide, two blood pressure lowering peptides that work mainly by reducing blood volume.

Store: aashay.com.au · Domain: aashay.com.au

Description

Targeting the multiple myeloma hypoxic niche with TH-302

Mendelson DS

tolerability

is a novel first in class

8-hexahydroquinoline-3-carboxylate

AHU-377 hemicalcium salt - CAS# 1369773-39-6 Catalog No.:M6489-2 Targeting the multiple myeloma hypoxicAHU 377 hemicalcium salt, CAS No. 1369773 39 6, is angiotensin receptor neprilysin inhibitor being studied for use in combination with valsartan for heart failure. Sacubitril is a prodrug that is activated to LBQ657 by de ethylation via esterases. LBQ657 inhibits the enzyme neprilysin, which is responsible for the degradation of atrial and brain natriuretic peptide, two blood pressure lowering peptides that work mainly by reducing blood volume.

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products